Latest Competition News

Harmoney has delivered a robust FY25 performance, exceeding its upgraded profit guidance with strong loan book growth and improved efficiency. The fintech lender projects a remarkable 111% increase in cash NPAT for FY26, driven by its AI-powered Stellare 2.0 platform and strategic expansion plans.

Harmoney Corp Limited has turned around its fortunes with a $5.5 million profit for FY25, reversing last year's loss, while revenue climbed nearly 8%. Despite the positive results, the company has not declared any dividends.

Patronus Resources has secured shareholder approval for a selective buy-back, signaling a strategic move to optimise its capital structure and potentially enhance shareholder value.

Xstate Resources has received pre-approval to acquire a 51% stake in the Diona project, setting the stage for drilling operations and ASX trading resumption by late September.

Elixinol Wellness has launched its Healthy Chef Protein Water range, entering Australia’s rapidly expanding $499 million protein supplements market with a clean-label, functional beverage lineup.

Iris Cairns Property Pty Ltd has increased its cash takeover offer for Reef Casino Trust units to A$3.72 per unit, with the Reef Corporate Services Limited board unanimously recommending acceptance. The offer values the trust at approximately A$185.3 million and awaits regulatory approvals.

Ainsworth Game Technology reported a steady half-year profit of $4.9 million on a 25% revenue increase, driven by strong domestic sales and new product launches, while navigating regional challenges and a looming Novomatic takeover bid.

Redcastle Resources Limited has resumed trading on the ASX following key announcements about a joint venture farm-out, a strategic placement, and a major gold project acquisition.

WOTSO’s FY25 results reveal a robust 14% increase in underlying EBITDA, driven by its expanding flexible workspace portfolio now spanning 31 locations. Strategic investments and partnerships underpin a confident outlook toward $58 million revenue by FY30.

WOTSO’s FY2025 results reveal an 11% revenue decline but a significantly reduced net loss, alongside a raised distribution payout, signaling cautious optimism amid market challenges.

Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.

FirstWave Cloud Technology is launching its first AI-powered compliance management feature for Open-AudIT, aiming to convert a large base of free users into paying customers through a subscription model integrated with AWS.